{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:42:34Z","timestamp":1789756954806,"version":"4.0.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\u2003<\/jats:title>\n                    <jats:p>Activating mutations of calcium-sensing receptor (CaSR) cause autosomal dominant hypocalcemia (ADH). ADH patients develop hypocalcemia, hyperphosphatemia, and hypercalciuria, similar to the clinical features of hypoparathyroidism. The current treatment of ADH is similar to the other forms of hypoparathyroidism, using active vitamin D3 or parathyroid hormone (PTH). However, these treatments aggravate hypercalciuria and renal calcification. Thus, new therapeutic strategies for ADH are needed. Calcilytics are allosteric antagonists of CaSR, and may be effective for the treatment of ADH caused by activating mutations of CaSR. In order to examine the effect of calcilytic JTT-305\/MK-5442 on CaSR harboring activating mutations in the extracellular and transmembrane domains in vitro, we first transfected a mutated CaSR gene into HEK cells. JTT-305\/MK-5442 suppressed the hypersensitivity to extracellular Ca2+ of HEK cells transfected with the CaSR gene with activating mutations in the extracellular and transmembrane domains. We then selected two activating mutations locating in the extracellular (C129S) and transmembrane (A843E) domains, and generated two strains of CaSR knock-in mice to build an ADH mouse model. Both mutant mice mimicked almost all the clinical features of human ADH. JTT-305\/MK-5442 treatment in vivo increased urinary cAMP excretion, improved serum and urinary calcium and phosphate levels by stimulating endogenous PTH secretion, and prevented renal calcification. In contrast, PTH(1-34) treatment normalized serum calcium and phosphate but could not reduce hypercalciuria or renal calcification. CaSR knock-in mice exhibited low bone turnover due to the deficiency of PTH, and JTT-305\/MK-5442 as well as PTH(1-34) increased bone turnover and bone mineral density (BMD) in these mice. These results demonstrate that calcilytics can reverse almost all the phenotypes of ADH including hypercalciuria and renal calcification, and suggest that calcilytics can become a novel therapeutic agent for ADH. \u00a9 2015 American Society for Bone and Mineral Research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbmr.2551","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T18:51:39Z","timestamp":1431456699000},"page":"1980-1993","source":"Crossref","is-referenced-by-count":63,"title":["Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH)"],"prefix":"10.1093","volume":"30","author":[{"given":"Bingzi","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Medical SciencesTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Medical SciencesTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyo","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Medical SciencesTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Medical SciencesTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoka","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology of Hard TissueHokkaido University Graduate School of Dental MedicineSapporoJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Amizuka","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology of Hard TissueHokkaido University Graduate School of Dental MedicineSapporoJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyonari","sequence":"additional","affiliation":[{"name":"Animal Resource Development UnitRIKEN Center for Life Science TechnologiesKobeJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Shioi","sequence":"additional","affiliation":[{"name":"Genetic Engineering TeamRIKEN Center for Life Science TechnologiesKobeJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Medical SciencesTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical SciencesTokushima UniversityTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical SciencesTokushima UniversityTokushimaJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"2024020319005025400_jbmr2551-bib-0001","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature."},{"key":"2024020319005025400_jbmr2551-bib-0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev."},{"key":"2024020319005025400_jbmr2551-bib-0003","doi-asserted-by":"crossref","DOI":"10.1210\/er.2009-0043","article-title":"The calcium-sensing receptor: a molecular perspective","volume":"32","author":"Magno","year":"2011","journal-title":"Endocr Rev."},{"key":"2024020319005025400_jbmr2551-bib-0004","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell."},{"key":"2024020319005025400_jbmr2551-bib-0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat Genet."},{"key":"2024020319005025400_jbmr2551-bib-0006","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","article-title":"Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism","volume":"5","author":"Baron","year":"1996","journal-title":"Hum Mol Genet."},{"key":"2024020319005025400_jbmr2551-bib-0007","first-page":"363","article-title":"A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia","volume":"84","author":"Okazaki","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s100380170124","article-title":"A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia","volume":"46","author":"Hirai","year":"2001","journal-title":"J Hum Genet."},{"key":"2024020319005025400_jbmr2551-bib-0009","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ymgme.2012.06.012","article-title":"CASR gene activating mutations in two families with autosomal dominant hypocalcemia","volume":"107","author":"Guarnieri","year":"2012","journal-title":"Mol Genet Metab."},{"key":"2024020319005025400_jbmr2551-bib-0010","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/01.ASN.0000025781.16723.68","article-title":"Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome","volume":"13","author":"Vargas-Poussou","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"2024020319005025400_jbmr2551-bib-0011","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1210\/jc.2013-3430","article-title":"Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia","volume":"99","author":"Kinoshita","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0012","first-page":"2497","article-title":"Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor","volume":"83","author":"Watanabe","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0013","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1210\/jcem.87.6.8531","article-title":"A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820) Phe) in the calcium-sensing receptor","volume":"87","author":"Nagase","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1677\/jme.0.0310255","article-title":"A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms","volume":"31","author":"Alvarez-Hernandez","year":"2003","journal-title":"J Mol Endocrinol."},{"key":"2024020319005025400_jbmr2551-bib-0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2011.04142.x","article-title":"Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia\u2014a German survey","volume":"75","author":"Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2024020319005025400_jbmr2551-bib-0016","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum Mol Genet."},{"key":"2024020319005025400_jbmr2551-bib-0017","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI118987","article-title":"Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells","volume":"98","author":"Pearce","year":"1996","journal-title":"J Clin Invest."},{"key":"2024020319005025400_jbmr2551-bib-0018","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med."},{"key":"2024020319005025400_jbmr2551-bib-0019","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1210\/jcem.86.11.8016","article-title":"Activating mutations of the calcium-sensing receptor: management of hypocalcemia","volume":"86","author":"Lienhardt","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0020","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int."},{"key":"2024020319005025400_jbmr2551-bib-0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2024020319005025400_jbmr2551-bib-0022","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Cutler GB Jr. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0023","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0024","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0026","doi-asserted-by":"crossref","first-page":"C221","DOI":"10.1152\/ajpcell.00139.2014","article-title":"Calcium-sensing receptor 20 years later","volume":"307","author":"Alfadda","year":"2014","journal-title":"Am J Physiol Cell Physiol."},{"key":"2024020319005025400_jbmr2551-bib-0027","doi-asserted-by":"crossref","first-page":"18990","DOI":"10.1074\/jbc.M400724200","article-title":"Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain","volume":"279","author":"Petrel","year":"2004","journal-title":"J Biol Chem."},{"key":"2024020319005025400_jbmr2551-bib-0028","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","journal-title":"Bone."},{"key":"2024020319005025400_jbmr2551-bib-0029","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/mol.109.058784","article-title":"Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications","volume":"76","author":"Saidak","year":"2009","journal-title":"Mol Pharmacol."},{"key":"2024020319005025400_jbmr2551-bib-0030","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1210\/en.2011-1426","article-title":"Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor","volume":"153","author":"Davey","year":"2012","journal-title":"Endocrinology."},{"key":"2024020319005025400_jbmr2551-bib-0031","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejphar.2011.07.015","article-title":"JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats","volume":"668","author":"Kimura","year":"2011","journal-title":"Eur J Pharmacol."},{"key":"2024020319005025400_jbmr2551-bib-0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0303-7207(98)00092-6","article-title":"Cloning and characterization of kidney-specific promoter of human PTH\/PTHrP receptor gene: absence of mutation in patients with pseudohypoparathyroidism type Ib","volume":"141","author":"Fukumoto","year":"1998","journal-title":"Mol Cell Endocrinol."},{"key":"2024020319005025400_jbmr2551-bib-0033","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1073\/pnas.96.5.2135","article-title":"Dynamic and quantitative Ca2+ measurements using improved cameleons","volume":"96","author":"Miyawaki","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024020319005025400_jbmr2551-bib-0034","doi-asserted-by":"crossref","first-page":"43389","DOI":"10.1074\/jbc.M205411200","article-title":"A molecular sensor detects signal transduction from caveolae in living cells","volume":"277","author":"Isshiki","year":"2002","journal-title":"J Biol Chem."},{"key":"2024020319005025400_jbmr2551-bib-0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1993.1458","article-title":"A novel ES cell line, TT2, with high germline-differentiating potency","volume":"214","author":"Yagi","year":"1993","journal-title":"Anal Biochem."},{"key":"2024020319005025400_jbmr2551-bib-0036","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/bbrc.1997.7111","article-title":"A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission","volume":"237","author":"Sakai","year":"1997","journal-title":"Biochem Biophys Res Commun."},{"key":"2024020319005025400_jbmr2551-bib-0037","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.0405516101","article-title":"Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification","volume":"101","author":"Hough","year":"2004","journal-title":"Proc Natl Acad Sci U S.A."},{"key":"2024020319005025400_jbmr2551-bib-0038","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0039","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jmicro\/dfs033","article-title":"Structure and formation of the twisted plywood pattern of collagen fibrils in rat lamellar bone","volume":"61","author":"Yamamoto","year":"2012","journal-title":"J Electron Microsc (Tokyo)."},{"key":"2024020319005025400_jbmr2551-bib-0041","doi-asserted-by":"crossref","first-page":"23605","DOI":"10.1074\/jbc.273.36.23605","article-title":"Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells","volume":"273","author":"Bai","year":"1998","journal-title":"J Biol Chem."},{"key":"2024020319005025400_jbmr2551-bib-0042","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/JPEM.2008.21.4.385","article-title":"Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion","volume":"21","author":"Sanda","year":"2008","journal-title":"J Pediatr Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0043","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00198-010-1441-9","article-title":"Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy","volume":"22","author":"Amrein","year":"2011","journal-title":"Osteoporos Int."},{"key":"2024020319005025400_jbmr2551-bib-0044","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone."},{"key":"2024020319005025400_jbmr2551-bib-0046","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0047","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology."},{"key":"2024020319005025400_jbmr2551-bib-0048","doi-asserted-by":"crossref","first-page":"E1692","DOI":"10.1210\/jc.2013-1974","article-title":"Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143","volume":"98","author":"Nakamura","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0049","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/jcem.85.12.7035","article-title":"Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?","volume":"85","author":"Yamamoto","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0050","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med."},{"key":"2024020319005025400_jbmr2551-bib-0051","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0052","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Invest."},{"key":"2024020319005025400_jbmr2551-bib-0053","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet."},{"key":"2024020319005025400_jbmr2551-bib-0054","doi-asserted-by":"crossref","first-page":"E1300","DOI":"10.1210\/jc.2013-3909","article-title":"Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3)","volume":"99","author":"Rogers","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0055","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1210\/jc.2013-3136","article-title":"Analysis of AP2S1, a calcium-sensing receptor regulator, in familial and sporadic isolated hypoparathyroidism","volume":"99","author":"Lambert","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2024020319005025400_jbmr2551-bib-0056","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/ml100268k","article-title":"Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone","volume":"2","author":"Shinagawa","year":"2011","journal-title":"ACS Med Chem Lett."},{"key":"2024020319005025400_jbmr2551-bib-0057","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/jbmr.1900","article-title":"A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305\/MK-5442 in humans","volume":"28","author":"Cabal","year":"2013","journal-title":"J Bone Miner Res."},{"key":"2024020319005025400_jbmr2551-bib-0058","doi-asserted-by":"crossref","first-page":"E2207","DOI":"10.1210\/jc.2013-4009","article-title":"A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis","volume":"99","author":"Halse","year":"2014","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2551","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/11\/1980\/56566383\/jbmr2551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/11\/1980\/56566383\/jbmr2551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:54:22Z","timestamp":1710327262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/30\/11\/1980-1993\/7599028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,5,12]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2551","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725496380.793523738","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11,1]]},"published":{"date-parts":[[2015,5,12]]}}}